MedPage Today on MSN
Ulcerative Colitis: Next Target for CAR T-Cell Therapy?
The range of autoimmune diseases treatable with chimeric antigen receptor (CAR) T-cell therapy could be much broader than ...
For decades, diagnosis of brain cancer has been medicine’s most difficult and hazardous challenge. Simple imaging such as MRI ...
The transcription factor NF-κB is a key regulator of cell fate, extensively involved in various physiological and pathological processes such as ...
Breakthrough T1D (formerly JDRF), the Lupus Research Alliance, and the National Multiple Sclerosis Society today announce the ...
This year, the GATE Life Sciences 2026 exam will be organised by IIT Guwahati. The official GATE Life Sciences syllabus PDF ...
Liver fibrosis, a pathological scarring process resulting from chronic liver injury, represents a significant global health ...
Scientists have engineered Salmonella bacteria to self-destruct inside tumors, releasing signals that spark powerful immune ...
A "heartbroken" family have called for access to specialist cancer treatments in Northern Ireland after the death of a ...
Six months ago, 4-year-old Jose Morales-Ortiz was struggling to say two-word sentences. Jose has severe autism, and he couldn ...
Nanjing Leads Biolabs Co., Ltd. ('Leads Biolabs' or the 'Company', Stock Code: 9887.HK) announced that the U.S. Food and Drug Administration (FDA) has approved its first-in-human Investigational New ...
Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that can improve the efficacy ...
Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company", Stock Code: 9887.HK) announced that the U.S. Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results